CVS Health Corporation $CVS Shares Bought by Equitable Holdings Inc.

Equitable Holdings Inc. boosted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 21.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,408 shares of the pharmacy operator’s stock after acquiring an additional 8,926 shares during the period. Equitable Holdings Inc.’s holdings in CVS Health were worth $5,215,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. BlackRock Inc. acquired a new stake in CVS Health during the second quarter worth about $12,747,462,000. Norges Bank purchased a new position in shares of CVS Health during the fourth quarter worth $1,666,265,000. Bank of America Corp DE increased its stake in CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the period. Wellington Management Group LLP boosted its stake in shares of CVS Health by 193.2% in the 4th quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after buying an additional 12,233,675 shares during the period. Finally, Pzena Investment Management LLC acquired a new stake in CVS Health in the second quarter valued at $1,217,558,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Down 1.5%

Shares of CVS Health stock opened at $92.88 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The stock has a market cap of $118.79 billion, a price-to-earnings ratio of 24.57, a price-to-earnings-growth ratio of 0.86 and a beta of 0.61. The company has a fifty day moving average price of $101.52 and a 200 day moving average price of $89.43.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period in the previous year, the company posted $1.81 EPS. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health’s dividend payout ratio is currently 70.37%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Wall Street Zen raised shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. HSBC restated a “hold” rating and issued a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. DA Davidson lifted their target price on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. UBS Group increased their price objective on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Finally, Mizuho lifted their target price on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.